James Kihara
PRINCIPAL ACCOUNTING OFFICER · ACADIA PHARMACEUTICALS INC
- 2024
- Jun 29, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies James Kihara files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark C. Schneyer - $1.13M in ACAD purchases and sales in the last 12 months
- James M. Daly - $671K in ACAD purchases and sales in the last 12 months
- Elizabeth H.Z. Thompson - $506K in ACAD purchases and sales in the last 12 months
- Adams Catherine Owen - $250K in ACAD purchases and sales in the last 12 months
- Jennifer J. Rhodes - $245K in ACAD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James Kihara?
James Kihara is a corporate insider, tracked as PRINCIPAL ACCOUNTING OFFICER of ACADIA PHARMACEUTICALS INC (ACAD). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did James Kihara last file a Form 4?
The most recent primary Form 4 on record is dated 29 June 2026, one of 11 filings going back to 2024.
Has James Kihara been buying or selling stock?
Recorded transactions: 0 open-market purchases and 13 open-market sales ($796K) across all tracked filings.
